# Kaposi's Varicelliform Eruption: A Serious and Potentially Fatal Complication of Darier's Disease

**Authors:** Rita Rosa Domingos, Pedro Reboredo, Ana Sara Monteiro, Cristina Sousa

PMC · DOI: 10.7759/cureus.79077 · Cureus · 2025-02-16

## TL;DR

A 48-year-old woman with Darier's disease developed a severe and potentially fatal viral infection called Kaposi's varicelliform eruption, which was successfully treated with antiviral and antibacterial therapy.

## Contribution

This case highlights the importance of early recognition and treatment of Kaposi's varicelliform eruption in patients with Darier's disease to prevent severe complications.

## Key findings

- Kaposi's varicelliform eruption in a Darier's disease patient presented with rapid progression and systemic symptoms.
- HSV-1/2 IgM positivity and Staphylococcus aureus superinfection were confirmed through laboratory testing.
- Intravenous acyclovir and flucloxacillin treatment led to significant clinical improvement.

## Abstract

Darier's disease (DD) is an autosomal dominant genetic disorder characterized by skin barrier dysfunction and chronic skin inflammation predisposing patients to secondary infections. Kaposi's varicelliform eruption (KVE), a severe viral infection, most commonly caused by herpes simplex virus (HSV), represents a life-threatening complication in these patients. The authors present the case of a 48-year-old woman with DD, who developed a progressive painful vesiculopustular eruption accompanied by systemic symptoms, including fever, bilateral otalgia, and ocular pain. The initial skin lesions, confined to the scapular region, rapidly spread to the face, periorbital region, and external ears. Clinical examination revealed vesiculopustular lesions, conjunctival hyperemia, and ear involvement. Laboratory testing confirmed HSV-1/2 immunoglobulin M (IgM) positivity, and blood cultures grew Staphylococcus aureus, indicating bacterial superinfection. The patient was treated with intravenous acyclovir and flucloxacillin, leading to significant clinical improvement. Clinicians should maintain a high index of suspicion for KVE in patients with DD presenting with vesicular rashes, particularly when systemic symptoms or rapid progression is observed. This case underscores the importance of early recognition of KVE in DD patients to facilitate timely antiviral and antibacterial treatment, reducing the risk of severe complications such as vision loss and permanent auditory impairment.

## Linked entities

- **Chemicals:** acyclovir (PubChem CID 135398513), flucloxacillin (PubChem CID 21319)
- **Diseases:** Darier's disease (MONDO:0007417)

## Full-text entities

- **Diseases:** painful (MESH:D010146), ocular pain (MESH:D058447), auditory impairment (MESH:D006311), KVE (MESH:D007617), vision loss (MESH:D014786), hyperemia (MESH:D006940), skin inflammation (MESH:D007249), autosomal dominant genetic disorder (MESH:D030342), bacterial superinfection (MESH:D015163), viral infection (MESH:D014777), infections (MESH:D007239), otalgia (MESH:D004433), fever (MESH:D005334), vesiculopustular lesions (MESH:D009059), skin barrier (MESH:D012871), vesicular rashes (MESH:D005076), vesiculopustular eruption (MESH:D003875), DD (MESH:D007644)
- **Species:** Staphylococcus aureus (species) [taxon 1280], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11920849/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11920849/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC11920849/full.md

---
Source: https://tomesphere.com/paper/PMC11920849